finasteride and Erectile Dysfunction

finasteride has been researched along with Erectile Dysfunction in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (12.28)	18.2507
2000's	19 (33.33)	29.6817
2010's	28 (49.12)	24.3611
2020's	3 (5.26)	2.80

Authors

Authors	Studies
Abbasi, B; Bell, A; Breyer, BN; Hakam, N; Li, KD; Low, P; Lui, J; Shaw, NM	1
Irwig, MS	1
Roehrborn, CG; Rukstalis, DB	1
Álvarez-Véliz, S; Berroeta-Mauriziano, D; Carrasco-Zuber, JE; Carreño-Orellana, N; Moll-Manzur, C; Porras-Kusmanic, N	1
Carrà, G; Caruso, D; Cavaletti, G; Diviccaro, S; Fusco, ML; Giatti, S; Grimoldi, M; Melcangi, RC; Santi, D; Simoni, M; Spezzano, R; Tabacchi, T	1
Corona, G; Dicuio, M; Gacci, M; Maggi, M; Mannucci, E; Maseroli, E; Santi, D; Sforza, A; Tirabassi, G	1
Darwin, E; Fertig, RM; Gamret, AC; Gaudi, S	1
Mehta, A; Said, MA	1
Choe, SJ; Lee, S; Lee, WS; Lee, YB	1
Coskuner, ER; Culha, MG; Ozkan, B	1
Andrade, C	1
Collier, R	1
Kormos, W	1
Kaplan, SA	2
Nole, KL; Tosti, A; Yim, E	1
Büttner, H; Esen, A; Glina, S; Henneges, C; Plekhanov, A; Roehrborn, CG; Sorsaburu, S; Viktrup, L	1
Doros, G; Haider, A; Haider, KS; Traish, AM	1
Brant, WO; Darke, A; Hotaling, JM; Myers, JB; Patel, DP; Schenk, JM	1
Seftel, AD	1
Pirozzi Farina, F; Pischedda, A	1
Arias-Santiago, S; Camacho-Martínez, FM	1
Kang, R; Li, E; Li, F; Liu, L; Luo, J; Luo, L; Wan, S; Zhao, S; Zhao, Z	1
Carviel, J; Gupta, AK; MacLeod, MA; Shear, N	1
Andersson, KE	1
Erdemir, F; Harbin, A; Hellstrom, WJ	1
Guay, AT; Hansen, ML; Hassani, J; Traish, AM; Zitzmann, M	1
Irwig, MS; Kolukula, S	1
Gao, PJ; Lu, YL; Shen, ZJ; Wang, XJ; Wu, W; Zhang, CM; Zhang, MG	1
Balercia, G; Corona, G; Forti, G; Maggi, M; Mannucci, E; Maseroli, E; Rastrelli, G; Sforza, A	1
Chung, DE; Kaplan, SA; Lee, RK; Scofield, S; Te, AE	1
Baconi, DL; Balalau, C; Constantin, VD; Dimcevici, NP; Georgescu, SR; Motofei, IG; Paunica, S; Rowland, DL	1
Gur, S; Hellstrom, WJ; Kadowitz, PJ	1
Kassabian, VS	1
Auerbach, S; Bach, MA; Bannow, J; Culbertson, J; Fitch, W; Grayhack, J; Herlihy, R; Labasky, R; Lee, M; Matsumoto, AM; Parra, R; Rajfer, J; Roy, J; Tenover, L; Waldstreicher, J; Wessells, H	1
Larson, TR	1
Andriole, GL; Bartsch, G; Boake, R; Bruskewitz, RC; Cook, T; Elhilali, M; Geller, J; Hudson, PB; Imperto-McGinely, J; Ko, A; Lieber, M; Lowe, FC; McConnell, JD; Nacey, JN; Pappas, F; Romas, NA; Shah, S; Stoner, E; Waldstreicher, J; Walsh, PC	1
Febbo, PG; George, DJ; Kantoff, PW; Kaplan, ID; Kaufman, DS; Leibowitz, SB; Manola, J; Oh, WK; Regan, MM; Smith, MR; Tay, MH	1
Atzori, L; Barbareschi, M; Benci, M; Pazzaglia, M; Rebora, A; Rossi, A; Soli, M; Tosti, A; Vena, GA; Voudouris, S	1
Doggrell, SA	1
Nehra, A	1
O'Leary, MP	1
Ankerst, DP; Coltman, CA; Darke, AK; Donaldson, GW; Ganz, PA; Langley, C; Lippman, SM; Moinpour, CM; Patrick, DL; Shumaker, SA; Thompson, IM; Ware, JE	1
Bartoletti, R; Cai, T; Gavazzi, A; Giubilei, G; Gontero, P; Lombardi, G; Mondaini, N	1
Fleshner, NE; Trachtenberg, J	1
Bono, AV; Fava, C	1
Trachtenberg, J	1
Edet, E; Freemantle, S; Mann, RD; Pearce, G; Stephens, MD; Wilton, L	1
Berlane, K; Brufsky, A; Fontaine-Rothe, P; Jiroutek, M; Kantoff, P; Kaplan, I; Kaufman, D; Rieker, P	1
Litwin, MS	1
Farré, M; Hernández-López, C; Peiró, AM	1
Asch, SM; Glassman, PA; Paige, NM; Passman, LJ; Shekelle, PG; Yu, EI	1
Vale, J	1
Fernández Navarro, F; Jerez Basurco, B; Martín Alvarez, M; Mora Navarro, G	1
Piraccini, BM; Soli, M; Tosti, A	1
Eaton, JD; Kirby, RS; Oades, GM	1
Andriole, GL; Bracken, BR; Bruskewitz, RC; Geller, J; Gormley, GJ; Imperato-McGinley, J; McConnell, JD; Stoner, E; Tenover, JS; Walsh, PC	1

Reviews

19 review(s) available for finasteride and Erectile Dysfunction

Article	Year
[Finasteride adverse effects: An update]. Revista medica de Chile, 2016, Volume: 144, Issue:12 Topics: 5-alpha Reductase Inhibitors; Alopecia; Blood Glucose; Erectile Dysfunction; Finasteride; Humans; Lipid Metabolism; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Spermatogenesis	2016
Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis. Andrology, 2017, Volume: 5, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Risk Factors; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome	2017
Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review. Dermatology online journal, 2017, Nov-11, Volume: 23, Issue:11 Topics: 5-alpha Reductase Inhibitors; Dose-Response Relationship, Drug; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Sexual Dysfunction, Physiological	2017
The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health. Current urology reports, 2018, Jun-16, Volume: 19, Issue:8 Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Infertility, Male; Libido; Male; Sexual Dysfunction, Physiological	2018
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta dermato-venereologica, 2019, 01-01, Volume: 99, Issue:1 Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Alopecia; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological	2019
Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors. Sexual medicine reviews, 2019, Volume: 7, Issue:2 Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological	2019
5α-Reductase inhibitors in androgenetic alopecia. Current opinion in endocrinology, diabetes, and obesity, 2014, Volume: 21, Issue:6 Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Drug Administration Schedule; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Patient Education as Topic; Treatment Outcome	2014
Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials. The journal of sexual medicine, 2016, Volume: 13, Issue:9 Topics: 5-alpha Reductase Inhibitors; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Middle Aged; Prostatic Hyperplasia; Randomized Controlled Trials as Topic	2016
5-alpha reductase inhibitors and erectile dysfunction: the connection. The journal of sexual medicine, 2008, Volume: 5, Issue:12 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Prostatic Hyperplasia	2008
Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. The journal of sexual medicine, 2011, Volume: 8, Issue:3 Topics: 5-alpha Reductase Inhibitors; Depression; Erectile Dysfunction; Finasteride; Humans; Libido; Male	2011
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation. Expert opinion on drug safety, 2013, Volume: 12, Issue:1 Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Male; Penile Erection; Prevalence; Prostatic Hyperplasia; Quality of Life; Risk Assessment; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Treatment Outcome	2013
Sexual function in patients treated for benign prostatic hyperplasia. Lancet (London, England), 2003, Jan-04, Volume: 361, Issue:9351 Topics: Adult; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Postoperative Complications; Prostatic Hyperplasia; Transurethral Resection of Prostate	2003
Current treatment options for benign prostatic hyperplasia and their impact on sexual function. Urology, 2003, Volume: 61, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Erectile Dysfunction; Finasteride; Humans; Laser Coagulation; Male; Middle Aged; Minimally Invasive Surgical Procedures; Prostatectomy; Prostatic Hyperplasia; Quality of Life; Quinazolines; Sexual Behavior; Transurethral Resection of Prostate	2003
After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Drug Delivery Systems; Drug Therapy, Combination; Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia	2004
Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia. BJU international, 2005, Volume: 96, Issue:3 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Male; Penile Erection; Prostatic Hyperplasia; Sexual Dysfunction, Physiological	2005
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
Healthcare resources should be targeted to chemoprevention: the argument against. European urology, 1996, Volume: 29 Suppl 2 Topics: Anticarcinogenic Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Health Care Rationing; Health Resources; Humans; Male; Primary Prevention; Prostatic Neoplasms; Public Opinion	1996
Benign prostatic hyperplasia and erectile dysfunction--is there a link? Current medical research and opinion, 2000, Volume: 16 Suppl 1 Topics: Adrenergic alpha-Antagonists; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Male; Postoperative Complications; Prostatic Hyperplasia; Transurethral Resection of Prostate	2000
The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia. Current urology reports, 2000, Volume: 1, Issue:2 Topics: Adrenergic alpha-Antagonists; Cardiovascular Physiological Phenomena; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia	2000

Trials

9 trial(s) available for finasteride and Erectile Dysfunction

Article	Year
Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride. The journal of sexual medicine, 2015, Volume: 12, Issue:1 Topics: Carbolines; Coitus; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Treatment Outcome	2015
Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. BJU international, 2016, Volume: 117, Issue:3 Topics: 5-alpha Reductase Inhibitors; Age Distribution; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors	2016
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology, 2003, Volume: 61, Issue:3 Topics: Aged; Double-Blind Method; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Incidence; Male; Middle Aged; Placebo Effect; Prostatic Hyperplasia; Severity of Illness Index; Sexual Dysfunctions, Psychological	2003
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia. Urology, 2003, Volume: 61, Issue:4 Topics: 5-alpha Reductase Inhibitors; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Placebos; Prostate; Prostatic Hyperplasia; Sexual Dysfunctions, Psychological; Treatment Outcome	2003
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. Journal of the National Cancer Institute, 2007, Jul-04, Volume: 99, Issue:13 Topics: Aged; Anticarcinogenic Agents; Cholestenone 5 alpha-Reductase; Double-Blind Method; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Longitudinal Studies; Male; Middle Aged; Placebos; Prostatic Neoplasms; Surveys and Questionnaires; Time Factors	2007
Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? The journal of sexual medicine, 2007, Volume: 4, Issue:6 Topics: Aged; Double-Blind Method; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Follow-Up Studies; Humans; Libido; Male; Middle Aged; Multivariate Analysis; Orgasm; Prostatic Hyperplasia; Sexual Behavior; Sexual Dysfunctions, Psychological; Surveys and Questionnaires	2007
Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate. Urology, 1997, Volume: 49, Issue:6 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Sexuality; Treatment Failure	1997
Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia. Journal of the European Academy of Dermatology and Venereology : JEADV, 2001, Volume: 15, Issue:5 Topics: Adolescent; Adult; Age Distribution; Alopecia; Case-Control Studies; Erectile Dysfunction; Finasteride; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Probability; Reference Values; Risk Assessment	2001
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. The New England journal of medicine, 1992, Oct-22, Volume: 327, Issue:17 Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Androstenes; Azasteroids; Dihydrotestosterone; Double-Blind Method; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Urodynamics	1992

Other Studies

29 other study(ies) available for finasteride and Erectile Dysfunction

Article	Year
5-Alpha reductase inhibitor related litigation: A legal database review. Andrology, 2022, Volume: 10, Issue:3 Topics: 5-alpha Reductase Inhibitors; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Male; Malpractice	2022
Finasteride and Suicide: A Postmarketing Case Series. Dermatology (Basel, Switzerland), 2020, Volume: 236, Issue:6 Topics: 5-alpha Reductase Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Alopecia; Case-Control Studies; Erectile Dysfunction; Finasteride; Humans; Male; Mental Disorders; Product Surveillance, Postmarketing; Sleep Initiation and Maintenance Disorders; Suicide; Young Adult	2020
Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia. European urology focus, 2022, Volume: 8, Issue:1 Topics: Doxazosin; Erectile Dysfunction; Finasteride; Humans; Male; Prostate; Prostatic Hyperplasia	2022
Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients. The Journal of steroid biochemistry and molecular biology, 2017, Volume: 171 Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Case-Control Studies; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Erectile Dysfunction; Evoked Potentials, Somatosensory; Finasteride; Humans; Incidence; Italy; Longitudinal Studies; Male; Pregnenolone; Progesterone; Prospective Studies; Psychiatric Status Rating Scales; Pudendal Nerve; Pudendal Neuralgia; Severity of Illness Index; Testosterone; Young Adult	2017
Why Odds Ratios Can Be Tricky Statistics: The Case of Finasteride, Dutasteride, and Sexual Dysfunction. The Journal of clinical psychiatry, 2018, 11-27, Volume: 79, Issue:6 Topics: 5-alpha Reductase Inhibitors; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Meta-Analysis as Topic; Odds Ratio; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Risk Assessment	2018
Propecia lawsuits: the lasting effects of delayed drug warnings. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Jul-09, Volume: 185, Issue:10 Topics: Canada; Drug Industry; Drug Labeling; Erectile Dysfunction; Finasteride; Humans; Male	2013
On call. I have read several news reports that claim finasteride, which I take for my prostate problem, can cause permanent impotence. Should I be concerned? Harvard men's health watch, 2013, Volume: 17, Issue:6 Topics: 5-alpha Reductase Inhibitors; Erectile Dysfunction; Finasteride; Health Status; Humans; Male; Prostatic Hyperplasia	2013
Re: inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. The Journal of urology, 2014, Volume: 191, Issue:3 Topics: 5-alpha Reductase Inhibitors; Azasteroids; Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sleep Wake Disorders	2014
Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Hormone molecular biology and clinical investigation, 2015, Volume: 23, Issue:3 Topics: Aged; Cohort Studies; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Testosterone; Urological Agents	2015
Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia. The Journal of urology, 2016, Volume: 195, Issue:1 Topics: Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia; Testosterone; Urological Agents	2016
Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2016, Jan-14, Volume: 87, Issue:4 Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug Monitoring; Dutasteride; Erectile Dysfunction; Evidence-Based Medicine; Finasteride; Humans; Male; Patient Selection; Prostatic Hyperplasia; Risk Assessment; Risk Factors	2016
Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? Actas dermo-sifiliograficas, 2016, Volume: 107, Issue:9 Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Insulin Resistance; Libido; Male; Osteoporosis; Prostatic Hyperplasia; Prostatic Neoplasms	2016
Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia. The Journal of urology, 2017, Volume: 197, Issue:1 Topics: Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia; Tamsulosin; Testosterone	2017
Assessing finasteride-associated sexual dysfunction using the FAERS database. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:6 Topics: 5-alpha Reductase Inhibitors; Adult; Databases, Factual; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; United States	2017
How many drugs for LUTS due to BPH are too many? The Journal of urology, 2008, Volume: 180, Issue:3 Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Imidazoles; Male; Muscarinic Antagonists; Phenylpropanolamine; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Tolterodine Tartrate; Triazines; Urination Disorders; Vardenafil Dihydrochloride	2008
Persistent sexual side effects of finasteride for male pattern hair loss. The journal of sexual medicine, 2011, Volume: 8, Issue:6 Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Chronic Disease; Dose-Response Relationship, Drug; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Sexual Dysfunction, Physiological; Young Adult	2011
Effects of oral finasteride on erectile function in a rat model. The journal of sexual medicine, 2012, Volume: 9, Issue:5 Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Animals; Dihydrotestosterone; Disease Models, Animal; Erectile Dysfunction; Finasteride; Male; Penile Erection; Penis; Prostate; Rats; Rats, Sprague-Dawley; Testosterone	2012
Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. Journal of endocrinological investigation, 2012, Volume: 35, Issue:10 Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Case-Control Studies; Cholestenone 5 alpha-Reductase; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Hyperplasia; Retrospective Studies; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Testosterone	2012
A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride. International journal of clinical practice, 2012, Volume: 66, Issue:11 Topics: 5-alpha Reductase Inhibitors; Azasteroids; Drug Substitution; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Gynecomastia; Humans; Libido; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies	2012
A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness. BJU international, 2013, Volume: 111, Issue:4 Pt B Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Erectile Dysfunction; Finasteride; Follow-Up Studies; Humans; Male; Men's Health; Patient Satisfaction; Penile Erection; Pilot Projects; Sexual Behavior; Surveys and Questionnaires	2013
Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:6 Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Neoplasm Staging; Nitriles; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds	2004
Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia. Archives of dermatology, 2004, Volume: 140, Issue:7 Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Adult; Alopecia; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Italy; Male; Sexual Behavior; Surveys and Questionnaires	2004
Treatment of advanced prostate cancer with the combination of finasteride plus flutamide: early results. European urology, 1993, Volume: 24 Suppl 2 Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Finasteride; Flutamide; Humans; Luteinizing Hormone; Male; Middle Aged; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone	1993
Benign prostatic hyperplasia. Age and type of treatment. Journal d'urologie, 1995, Volume: 101, Issue:1 Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Postoperative Complications; Prostatectomy; Prostatic Hyperplasia	1995
The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients. British journal of urology, 1996, Volume: 78, Issue:3 Topics: Adolescent; Adult; Aged; Cohort Studies; Ejaculation; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Gynecomastia; Hair Diseases; Humans; Libido; Male; Middle Aged; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Urination Disorders	1996
Urology. JAMA, 1999, Feb-10, Volume: 281, Issue:6 Topics: Circumcision, Male; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Male; Mass Screening; Pain; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatic Neoplasms; Purines; Serenoa; Sildenafil Citrate; Sulfones; Urology	1999
[Medications of wellbeing]. Atencion primaria, 2000, Sep-15, Volume: 26, Issue:4 Topics: Aged; Alopecia; Anti-Obesity Agents; Drug Prescriptions; Drug Therapy; Enzyme Inhibitors; Erectile Dysfunction; Female; Finasteride; Humans; Lactones; Male; Middle Aged; Nonprescription Drugs; Obesity; Orlistat; Phosphodiesterase Inhibitors; Piperazines; Psychotropic Drugs; Purines; Sildenafil Citrate; Sulfones	2000
Cost-sharing for prescriptions of sildenafil and finasteride: a case study in veteran patients. The American journal of managed care, 2001, Volume: 7, Issue:4 Topics: Adult; Aged; Alopecia; Attitude to Health; Cost Sharing; Drug Costs; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Health Care Surveys; Hospitals, Veterans; Humans; Los Angeles; Male; Middle Aged; Piperazines; Purines; Sildenafil Citrate; Sulfones	2001
[Wellbeing or happiness medications?]. Atencion primaria, 2001, Jun-30, Volume: 28, Issue:2 Topics: Alopecia; Anti-Obesity Agents; Enzyme Inhibitors; Erectile Dysfunction; Family Practice; Finasteride; Humans; Lactones; Male; Obesity; Orlistat; Piperazines; Purines; Sildenafil Citrate; Sulfones	2001